SYMBIOTIC CAPITAL

other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}
cb

Adviser Profile
As of Date 05/16/2024
Adviser Type - Large advisory firm
Number of Employees 5
of those in investment advisory functions 4
Registration SEC, Approved, 07/28/2023
Other registrations (4)
Former registrations

SYMBIOTIC CAPITAL MANAGEMENT CO. LLC

AUM* 252,499,111
of that, discretionary 252,499,111
Private Fund GAV* 252,499,111 15.67%
Avg Account Size 126,249,556
SMA’s No
Private Funds 2
Contact Info 424 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
1 1 1 1

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeOther Private Fund Count2 GAV$252,499,111

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser GLL INVESTORS Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund187.2m Total Private Fund GAV187.2m AUM188.1m #Funds5
Adviser KARLOV STREET CAPITAL, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund257.2m Total Private Fund GAV257.2m AUM257.2m #Funds27
Adviser VIRTERA PARTNERS LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund161.5m Total Private Fund GAV161.5m AUM346.9m #Funds5
Adviser CRESCENDO ASSET MANAGEMENT LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV- AUM184.5m #Funds-
Adviser MONTCALM TCR LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund3.0m Total Private Fund GAV3.0m AUM199.4m #Funds1
Adviser PAN GLOBAL ADVISERS, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund21.7m Total Private Fund GAV21.7m AUM200.2m #Funds1
Adviser MASON CAPITAL PARTNERS Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund117.8m Total Private Fund GAV117.8m AUM200.5m #Funds3
Adviser PRESERVER PARTNERS Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund165.5m Total Private Fund GAV165.5m AUM172.9m #Funds2
Adviser VCFA GROUP Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund417.6m Total Private Fund GAV417.6m AUM298.2m #Funds7
Adviser STOCK FARM PARTNERS LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund154.0m Total Private Fund GAV154.0m AUM154.0m #Funds3

Brochure Summary

Overview

Symbiotic Capital Management Co. LLC (“Symbiotic Capital,” the “Adviser,” “our,” or “we”) is a Delaware limited liability company located in Los Angeles, California, and founded in September 2022 by Symbiotic Capital, LLC. Symbiotic Capital is a first-of-its-kind life science credit platform and aspires to be the preferred credit partner for innovative life science companies. The Adviser is backed by Bellco Capital LLC’s (“Bellco Capital”) preeminent life science ecosystem, which, over the past three decades, has incubated and built leading life science companies (such as Kite Pharma), invested in transformational science, and developed life science real estate across the globe. Symbiotic Capital’s participation in this ecosystem actively empowers our investment sourcing and portfolio value creation. In addition, Symbiotic Capital has access to numerous companies, academia, investors, and pharma partners via the Bellco Capital life science ecosystem and will seek to leverage these relationships across all aspects of the credit business, from deal sourcing to adding
value to the underlying borrowers. Symbiotic Capital provides advisory services to the Symbiotic Life Sciences Credit Fund and the Symbiotic Capital Life Science Credit Parallel Fund GP, L.P. (the “Funds” or the “Clients”). The Funds offer investors the opportunity to own a curated portfolio of secured credit investments in the development stage and commercial stage life science companies. Symbiotic Capital focuses on looking for opportunities to enhance borrower value through the life of the loan and, as necessary, to leverage its life science heritage and ecosystem to manage downside scenarios. As of December 2023, Symbiotic Capital has $252,499,111 in discretionary assets under management. Persons reviewing this Form ADV Part 2A should not construe this as an offering of the Funds described herein, which will only be made pursuant to the delivery of a private placement memorandum, subscription agreement, and/or similar documentation to prospective investors. Symbiotic Capital does not participate in wrap fee programs or advise client assets on a non- discretionary basis.